Heated tobacco product

Health Canada makes it legal for flavoured nicotine products from Imperial Tobacco to be sold to children

Retrieved on: 
화요일, 11월 14, 2023
Smoke, Sale, Minister, Disclosure, American Tobacco Company, British American Tobacco, Health Canada, Imperial Brands, Heated tobacco product, Food, Canadian Lung Association, Social enterprise, Herbal cigarette, Imperial Tobacco Canada, Food and Drugs Act, Minor, ASH, Government, COP10, Canadian Cancer Society, Research, Candy, Tobacco industry, Marketing, Advertising, Social media, Conference, Natural health product, School, Person, Tobacco, Smoking, Overalls, Outline, Legislation, Pharmacy, Medicinal plants, Physician, Nicotine, Health

OTTAWA, ON, Nov. 14, 2023 /CNW/ - Health Canada has approved the sale of flavoured nicotine pouches by Imperial Tobacco Canada Ltd. in such a way that the products can be legally sold to children of any age.

Key Points: 
  • OTTAWA, ON, Nov. 14, 2023 /CNW/ - Health Canada has approved the sale of flavoured nicotine pouches by Imperial Tobacco Canada Ltd. in such a way that the products can be legally sold to children of any age.
  • On July 18, 2023, a sister company of Imperial Tobacco was given approval to sell flavoured nicotine pouches under the Natural Health Product Regulations, with the products containing nicotine but not tobacco.
  • It is completely legal for stores to sell these flavoured nicotine pouches to children of any age.
  • How can it possibly be legal to sell to children flavoured nicotine products from a tobacco company?"

Pyxus International, Inc. Reports Fiscal Year 2024 Second Quarter Results with Strong Top and Bottom Line Results

Retrieved on: 
화요일, 11월 14, 2023
Sale, EBITDA, Webcast, Pandemic, Reproduction, Heated tobacco product, Security (finance), Foreign Corrupt Practices Act, OTC Markets Group, Visibility, Policastro Bussentino, Annual report, Nationalization, Collection, Pyxus International, Risk, Exercise, Government, Second Half, Tobacco, Weather, Farmer, Table, GAAP, Adjustment, Geography, Death, Growth, Failure, Retail, Video game, Hamas

MORRISVILLE, N.C., Nov. 14, 2023 /PRNewswire/ -- Pyxus International, Inc. (OTC Pink: PYYX) ("Pyxus," the "Company," "we," or "our"), a global value-added agricultural company, today announced results for its fiscal quarter ended September 30, 2023.

Key Points: 
  • Pieter Sikkel, Pyxus' President and Chief Executive Officer, stated, "The momentum we built during the first quarter continued in the second quarter.
  • Second quarter sales and other operating revenues grew by 22.8% to $624.3 million, an increase of $116.0 million over the second quarter of fiscal 2023.
  • Pyxus achieved a gross margin of 14.2% of revenues, which represents a full percentage point of increased profitability over the year-ago second quarter.
  • The Company increased second quarter operating income to $46.3 million as compared to $27.1 million in the prior year's second quarter.

FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus

Retrieved on: 
목요일, 11월 9, 2023
Priority review, Tenderness, Viremia, Safety, Heated tobacco product, Food, Rash, Headache, Risk, Disease, Myalgia, Clinical trial, Fatigue, Vaccination, Multimedia, Research, Rest, FDA, Animal, Vaccine, Cosmetics, Blood, Human services, Dietary supplement, Nausea, Infection, Gestational age, Trial of the century, Primate, Arthralgia, Pain, Fetus, Food and Drug Administration, Fever, Accelerated approval (FDA), Public, Pharmaceutical industry, Chikungunya

Chikungunya is an emerging global health threat with at least 5 million cases of chikungunya virus infection reported during the past 15 years.

Key Points: 
  • Chikungunya is an emerging global health threat with at least 5 million cases of chikungunya virus infection reported during the past 15 years.
  • However, chikungunya virus has spread to new geographical areas causing a rise in global prevalence of the disease.
  • It contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
  • Transmission of chikungunya virus to newborn babies from pregnant individuals with viremia (virus present in the blood) at delivery has been reported and can cause severe, potentially fatal chikungunya virus disease in newborns.

FDA Clears First COVID-19 Home Antigen Test

Retrieved on: 
목요일, 11월 9, 2023
Shenzhen Kangtai Biological Products, Safety, Heated tobacco product, Food, Ageing, Laboratory, Lower respiratory tract infection, Multimedia, FDA, Vaccine, Animal, Marketing, COVID-19, Cosmetics, Human services, Dietary supplement, OTC, Public, COVID, Device

ACON Laboratories' Flowflex COVID-19 Antigen Home Test, originally authorized for emergency use in 2021, is now the second home COVID-19 test to successfully complete a traditional FDA premarket review pathway, and the first indicated for use in children under 18.

Key Points: 
  • ACON Laboratories' Flowflex COVID-19 Antigen Home Test, originally authorized for emergency use in 2021, is now the second home COVID-19 test to successfully complete a traditional FDA premarket review pathway, and the first indicated for use in children under 18.
  • The Flowflex COVID-19 Antigen Home Test is a visually-read test cleared for OTC home use by symptomatic individuals within six days of symptom onset.
  • This means that a symptomatic individual with an initial negative test result should be re-tested once between 48 and 72 hours after the first test using an antigen test for COVID-19 or followed up with a molecular COVID-19 test.
  • The FDA reviewed the ACON Flowflex COVID-19 Antigen Home Test through the 510(k) premarket review pathway.

Rothmans, Benson & Hedges Launches New Smoke-Free Heated Tobacco Product in Push to Lead Smoking Harm Reduction

Retrieved on: 
목요일, 11월 9, 2023
Policy, Smoking, Benson, Smoke, Disease, PMI, Philip Morris International, Nicotine, Heated tobacco product, RBH, Science, N.B, Rothmans, Smoker, Tobacco, Burn

RBH's new heated tobacco product is the latest expansion of the company's growing portfolio of smoke-free innovations.

Key Points: 
  • RBH's new heated tobacco product is the latest expansion of the company's growing portfolio of smoke-free innovations.
  • The new bladeless SMARTCORE INDUCTION SYSTEM™ provides improved experience and is now available in select stores across Canada with four tobacco flavour options.
  • Cigarettes burn tobacco and create smoke, which contains high levels of harmful or potentially harmful chemicals – the primary cause of smoking related disease.
  • Under the federal Tobacco and Vaping Products Act, naming a heated tobacco product could be considered promotion.

22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License

Retrieved on: 
화요일, 11월 7, 2023
FDA, Patent, Health, Smoke, Smoking, GMO, Century, Pacific Century Group, North Carolina State University, Public, Smoker, Nicotine, IP, Heated tobacco product, MRTP, Tobacco

BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signing of an additional reduced nicotine content technology license with North Carolina State University.

Key Points: 
  • BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis, and hops, today announced the signing of an additional reduced nicotine content technology license with North Carolina State University.
  • The latest license provides additional modes of efficiently producing reduced nicotine content tobacco plants, extending 22nd Century’s already extensive IP portfolio.
  • The license will provide 22nd Century Group exclusive rights to the technology until 2042.
  • “This latest license further enhances and expands on our capabilities to produce reduced nicotine content tobacco plants as we work to bring these innovative products to market for the betterment of public health, including by enhancing our capability to produce reduced nicotine content tobacco plants suitable for international markets that are opposed to genetically modified plants.”
    Under terms of the exclusive license, 22nd Century will have full use of the patent rights and plant materials to develop and commercialize reduced nicotine content tobacco using this latest non-GMO technology, which further enables worldwide marketability of the Company’s VLN® reduced nicotine content products.

Quit for Good Signs Global Statement of Support for Tobacco Harm Reduction

Retrieved on: 
화요일, 11월 7, 2023
Knowledge, Ecologist Green Party (Moldova), Harm reduction, Health care, Heated tobacco product, Tobacco, COP10, Public, Nicotine, Good, Health, THR, European Medical Association, Organization, NRT, Smoking, Harm, Environmental disease, Reduction, Herbal cigarette, EMA, FCTC, Patient, WHO, Conference, Public Health England, Society, Annual Review, Public health, Government, Smoke, International Association, Conference of the parties, Smoker, KABAR, EU, Party

Quit For Good is a non-profit organization promoting harm reduction to mitigate the damage caused by cigarette smoke on human health.

Key Points: 
  • Quit For Good is a non-profit organization promoting harm reduction to mitigate the damage caused by cigarette smoke on human health.
  • It is one of the 14 scientific organizations in four continents who support the consensus statement of SCOHRE that the WHO FCTC should not ignore the evidence in support of THR any more.
  • It is also one of the two organizations based in the Philippines that signed the statement, the other being the Harm Reduction Alliance of the Philippines (HARAP).
  • He said providing safer nicotine products to reduce harm for smokers is common sense as smokers are already offered nicotine replacement therapy (NRT) to quit or reduce harm.

Rite Aid to Honor Military Service Members with Veteran Appreciation Discount

Retrieved on: 
목요일, 11월 2, 2023
Defense, Retail, Health, Convenience Store, Specialty, Pharmaceutical, Veterans, OTC, Aid, Prescription, Veteran, Heated tobacco product, Rite Aid, Online shopping

Rite Aid (OTC: RADCQ) is proud to recognize the service and sacrifice of all veterans and active military personnel this Veterans’ Day by offering a “Veteran Appreciation Days” promotion.

Key Points: 
  • Rite Aid (OTC: RADCQ) is proud to recognize the service and sacrifice of all veterans and active military personnel this Veterans’ Day by offering a “Veteran Appreciation Days” promotion.
  • From Nov. 10-12, customers with a valid military ID or proof of service are eligible for 15% off regular-priced items* at any Rite Aid store location.
  • Rite Aid customers must be members of the Rite Aid Rewards program, and enrollment is available in-store or online.
  • “Veterans’ Day is an important time to recognize and appreciate the sacrifices so many have made for our country and the freedoms we have today,” said Jeanniey Walden, Chief Marketing Officer at Rite Aid.

Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance Across Pharmaceuticals, Medical Devices, Biologics, and Tobacco Products - ResearchAndMarkets.com

Retrieved on: 
수요일, 11월 1, 2023
Technology, Pharmaceutical, Health, Data Management, Knowledge, FDA, Quality control, Pharma, Organization, Research, Artificial intelligence, Machine learning, Automation, Heated tobacco product, Fine chemical

The "Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance" training has been added to ResearchAndMarkets.com's offering.
  • This seminar is specifically tailored for professionals working in FDA-regulated industries, including pharmaceuticals, medical devices, biologics, and tobacco products such as e-liquids, e-cigarettes, pouch tobacco, and cigars.
  • The central theme of this seminar is "Data Integrity by Design," which is a critical concept that organizations operating in FDA-regulated industries must adopt.
  • This is where an integrated laboratory software system plays a crucial role by streamlining processes and upholding data integrity.

National Survey Shows Drop in E-Cigarette Use Among High School Students

Retrieved on: 
목요일, 11월 2, 2023
FDA, Sale, Fruit, Physical examination, Food, Health, Korea Disease Control and Prevention Agency, Tobacco smoking, Regulation of tobacco by the U.S. Food and Drug Administration, Conflict, Center for Tobacco Products, Ice, CMP, CDC, Candy, Public, Heated tobacco product, Menthol, JUUL, Tobacco

SILVER SPRING, Md., Nov. 2, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), released data from the 2023 National Youth Tobacco Survey (NYTS) on tobacco product use among U.S. youth. The findings, which were collected between March and June 2023, show that 10% of U.S. middle and high school students (2.8 million youth) reported current use of any tobacco product.

Key Points: 
  • Among U.S. high school students, current overall tobacco product use declined during 2022-2023 (16.5% to 12.6%).
  • Among high school students, declines in current use were also observed during 2022-2023 for cigars and overall combustible tobacco smoking, representing all-time lows.
  • Although a decrease in e-cigarette use was observed among high school students, among middle school students there was an increase in current overall tobacco product use (4.5% to 6.6%) and multiple tobacco product use (1.5% to 2.5%).
  • E-cigarettes remained the most commonly used tobacco product among both high school and middle school students for the 10th year in a row.